Terms: = Ovarian cancer AND TP63, EEC3, 8626, ENSG00000073282, p73H, p63, Q9H3D4, TP73L, p51, OFC8, KET, RHS, B p51B , B p51A , SHFM4, LMS, p73L AND Diagnosis
32 results:
1. High-grade Serous Carcinoma can Show Squamoid Morphology Mimicking True Squamous Differentiation.
Tomonobe H; Ohishi Y; Hachisuga K; Yahata H; Kato K; Oda Y
Am J Surg Pathol; 2023 Sep; 47(9):967-976. PubMed ID: 37382102
[TBL] [Abstract] [Full Text] [Related]
2. Dominant tp63 missense variants lead to constitutive activation and premature ovarian insufficiency.
Tucker EJ; Gutfreund N; Belaud-Rotureau MA; Gilot D; Brun T; Kline BL; Bell KM; Domin-Bernhard M; Théard C; Touraine P; Robevska G; van van den Bergen J; Ayers KL; Sinclair AH; Dötsch V; Jaillard S
Hum Mutat; 2022 Oct; 43(10):1443-1453. PubMed ID: 35801529
[TBL] [Abstract] [Full Text] [Related]
3. Utility of p63 and PTEN staining in distinguishing cervical microglandular hyperplasia from endometrial endometrioid carcinoma with microglandular/mucinous features.
Aoun BA; Skala SL
Histopathology; 2022 Jun; 80(7):1102-1111. PubMed ID: 35347751
[TBL] [Abstract] [Full Text] [Related]
4. NUT Carcinoma in the Pelvic Cavity With Unusual Pathologic Features.
Jung M; Kim SI; Kim JW; Jeon YK; Lee C
Int J Gynecol Pathol; 2022 May; 41(3):292-297. PubMed ID: 34166280
[TBL] [Abstract] [Full Text] [Related]
5. Incidence of and risk factors associated with lung metastases in newly diagnosed epithelial ovarian cancer with a look on prognosis after diagnosis: a population-based cohort study of the SEER database.
Xu J; Hussain I; Wang L; Deng K; Zhao L; Zhou K; Zhang L; Xu Z; Li K
Arch Gynecol Obstet; 2021 Oct; 304(4):1007-1020. PubMed ID: 33635405
[TBL] [Abstract] [Full Text] [Related]
6. Metastatic ovarian cancer spreading into mammary ducts mimicking an in situ component of primary breast cancer: a case report.
Maeshima Y; Osako T; Morizono H; Yunokawa M; Miyagi Y; Kikuchi M; Ueno T; Ohno S; Akiyama F
J Med Case Rep; 2021 Feb; 15(1):78. PubMed ID: 33593410
[TBL] [Abstract] [Full Text] [Related]
7. Evaluation of cell blocks from effusion specimens in Gynecologic Oncopathology: An experience of 220 cases, diagnosed at a Tertiary cancer Referral Center.
Rekhi B; Karmarkar S; Gupta C; Deodhar KK; Menon S; Pathuthara S; Maheshwari A; Shylasree TS; Gupta S
Indian J Pathol Microbiol; 2020; 63(3):427-434. PubMed ID: 32769333
[TBL] [Abstract] [Full Text] [Related]
8. Extraovarian Brenner tumor in the uterus: a case report and review of literature.
Hu RY; Deng YJ; Zhu HH; Zhou J; Hu M; Liang XQ; Xiao QJ; Zhou L; Peng XY; Zhang XW; Ji N; Deng H
Diagn Pathol; 2020 Mar; 15(1):22. PubMed ID: 32164751
[TBL] [Abstract] [Full Text] [Related]
9. [Clinicopathological features of ovarian Brenner tumors].
Zhong PP; Zhu L; Zhang LH; Zheng XZ; Chen TB; Xu F; Zhan Y; Yin CH; Jin YL
Zhonghua Bing Li Xue Za Zhi; 2019 Aug; 48(8):615-619. PubMed ID: 31422592
[No Abstract] [Full Text] [Related]
10. The role of immunohistochemical examination in diagnosis of papillary thyroid cancer in struma ovarii.
Szczepanek-Parulska E; Pioch A; Cyranska-Chyrek E; Wolinski K; Jarmołowska-Jurczyszyn D; Janicka-Jedynska M; Majewski P; Zabel M; Ruchala M
Folia Histochem Cytobiol; 2019; 57(1):35-42. PubMed ID: 30924920
[TBL] [Abstract] [Full Text] [Related]
11. Imaging findings of ovarian leiomyosarcoma with histopathologic correlations.
Fischetti A; Rutigliani M; Romano N; Marinaro EL; Puppo C; Gorlero F; Melani EF; Rollandi GA
Eur J Obstet Gynecol Reprod Biol; 2019 May; 236():261-262. PubMed ID: 30898403
[TBL] [Abstract] [Full Text] [Related]
12. Safety of ovarian preservation in premenopausal women with stage I uterine sarcoma.
Nasioudis D; Chapman-Davis E; Frey M; Holcomb K
J Gynecol Oncol; 2017 Jul; 28(4):e46. PubMed ID: 28541635
[TBL] [Abstract] [Full Text] [Related]
13. Molecular Pathology and Novel Clinical Therapy for Uterine Leiomyosarcoma.
Hayashi T; Kawano M; Ichimura T; Ida K; Ando H; Zharhary D; Kanai Y; Aburatani H; Tonegawa S; Shiozawa T; Yaegashi N; Konishi I
Anticancer Res; 2016 Oct; 36(10):4997-5007. PubMed ID: 27798858
[TBL] [Abstract] [Full Text] [Related]
14. How to approach the many faces of endometrioid carcinoma.
Malpica A
Mod Pathol; 2016 Jan; 29 Suppl 1():S29-44. PubMed ID: 26715172
[TBL] [Abstract] [Full Text] [Related]
15. Expression of HNF-1β in cervical carcinomas: an immunohistochemical study of 155 cases.
Němejcová K; Cibula D; Dundr P
Diagn Pathol; 2015 Mar; 10():8. PubMed ID: 25884453
[TBL] [Abstract] [Full Text] [Related]
16. Extrauterine epithelioid trophoblastic tumor arising in the ovary with multiple metastases: a case report.
Arafah MA; Tulbah AM; Al-Husaini H; Al-Sabban M; Al-Shankiti H; Al-Badawi IA
Int J Surg Pathol; 2015 Jun; 23(4):339-44. PubMed ID: 25695493
[TBL] [Abstract] [Full Text] [Related]
17. CA125 expression in the tissue of uterine leiomyosarcoma.
Menczer J; Schreiber L; Berger E; Ben-Shem E; Golan A; Levy T
Isr Med Assoc J; 2014 Nov; 16(11):697-9. PubMed ID: 25558698
[TBL] [Abstract] [Full Text] [Related]
18. Management of primary retroperitoneal sarcoma (RPS) in the adult: a consensus approach from the Trans-Atlantic RPS Working Group.
Trans-Atlantic RPS Working Group
Ann Surg Oncol; 2015 Jan; 22(1):256-63. PubMed ID: 25316486
[TBL] [Abstract] [Full Text] [Related]
19. A genetic variant in p63 (rs17506395) is associated with breast cancer susceptibility and prognosis.
Zhang N; Huo Q; Wang X; Chen X; Long L; Guan X; Jiang L; Ma T; Hu W; Yang Q
Gene; 2014 Feb; 535(2):170-6. PubMed ID: 24316488
[TBL] [Abstract] [Full Text] [Related]
20. Use of immunohistochemistry in the diagnosis of problematic breast lesions.
Lee AH
J Clin Pathol; 2013 Jun; 66(6):471-7. PubMed ID: 23486609
[TBL] [Abstract] [Full Text] [Related]
[Next]
